Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Andrew Paxton

MRPharmS, Lancaster

Recent stories

  • My concerns with changes to the conscience clauseSubscription

    17 JAN 2017Comments (1)

    I read with interest about the proposed change to the conscience clause for pharmacists (The Pharmaceutical Journal online, 22 December 2016). This concerns me. I have been a Christian for 59 years and a pharmacist for 36 years. One of the reasons I chose pharmacy was that, unlike medic

  • DM+D should reflect prescribing intentionsSubscription

    19 APR 2014

    I am fortunate that I work in Cumbria, where the electronic prescriptions service is running well. However, the system relies on there being entries in the Dictionary of Medicines and Devices (DM+D) for the products prescribed. Some products do not appear because the prescribing is not specific enough, such as Gaviscon Advance without specifying the flavour. But one product that never appears is paracetamol caplets 500mg. This is because the product is considered to be just paracetamol tablet

  • EPS’s crooked spineSubscription

    Online, February 2014

    It has been noticeable to everyone struggling with the electronic prescription service over the past few weeks how unreliable the NHS “spine” has been. Hardly a day has gone by without a text message or email from the service notifications of the Health and Social Care Information Centre apologising for service delays or interruptions. If the EPS is going to succeed, as I hope it will, the IT needs to be improved drastically. Andrew Paxton Lancaste

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.